Clinical Data on ST-001 nanoFenretinide™ to be presented at USCLC Annual Workshop 2026
Clinical Data on ST-001 nanoFenretinide™ to be presented at USCLC Annual Workshop 2026 NEWS PROVIDED BY SciTech Development, Inc. Mar 25, 2026, 09:00 ET Results Highlight Early Clinical Benefit, High Systemic Exposure, and Manageable Toxicity in Cutaneous T-Cell Lymphoma Patients DETROIT, March 25, 2026 /PRNewswire/ — SciTech Development Inc., a clinical-stage oncology company advancing…